ARCHIVES

Nature Editorial Criticizes NCI PR Spending

This article is from The Cancer Letter archive.

Vol. 39 No. 11 | March 15, 2013

Download PDF Visit The Full Archive

Related Articles

Komen Under Pressure: Charity Faces Money Woes, Attacks from Right

October 26, 2012

Medicare plans to cut oncology payments on Jan. 1 unless Congress intervenes.

October 17, 2003

FDA Concerned About Data-Dredging In Drug-Diagnostic Applications

January 30, 2009

White House Announces FDA Initiatives To accelerate Cancer Drug Approval

April 4, 1996

William Tipping New ACS Executive VP; Murphy To Replace Holleb, Laszio Takes Rauscher’s Position

March 4, 1988

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

April 15, 1977